openPR Logo
Press release

Cryptocurrency Hits High Ends Suddenly As the Stock Market Begins Trading

11-02-2018 01:15 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: LupusCoin

The biggest and strongest names in cryptocurrencies reached a strong ground today as tether, a token designed to be linked to the U.S. dollar, fell more than 2.3 percent.
Ether, Bitcoin and XRP, are the three biggest cryptocurrencies on the current market and today rose by around 7% higher…Bitcoin went from €5,440.47 to €6,245.05 when the market first opened today around 8am London time.
Sarah Doherty from LupusCoin (www.lupuscoin), “compared to last month where the stock market shed billions in capitalization, this is a great turn of events.”
“When you see a token like Ether dropping more than 2.3%, it means there is availability for other tokens to make their way to the top of the chart,” says Mrs. Doherty LupusCoin.
The high end cryptocurrencies out there are still well off their record highs, bitcoin off by more than 66 percent compared to previous figures , XPR has dropped down more than 88 percent and tether as mentioned above down 84 percent, and could drop more.
Many people have been questioning whether or not if Ether was created to manipulate the price of Bitcoin. Many people nowadays are questioning the motives behind it and wondering if it can hold a stable value, and perhaps make the decision to remove their funds while they can and shift their investments to other cryptocurrencies while they still have the chance.
Mrs. Doherty from LupusCoin says. “We have recently launched LupusCoin which is an ICO backed up by a short term letting meaning we are now able to facilitate investors of all sizes investing not only in rental properties, but also receiving an income via the dividends produced from property rental.”
For more information on LupusCoin, please click the following link:
www.lupuscoin.com

LupusCoin.com is owned and operated by Lupus Rental Ltd., (www.lupusrent.com) a company established to provide a solution to investment in the rentals marketplace whilst simultaneously providing a rental and crowd sale platform for real estate. Historically only those individuals with substantial financial assets have had access to invest in the property markets, but with the influx of digital currencies in 2017 we are now able to facilitate investors of all sizes investing not only in rental properties, but also receiving an income via the dividends produced from property rental.

Orla Conway
29 Ashbourne Tower,
Canary Wharf, E17 2FR

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cryptocurrency Hits High Ends Suddenly As the Stock Market Begins Trading here

News-ID: 1346638 • Views:

More Releases from LupusCoin

LupusCoin to Discuss Their New ICO This Week
LupusCoin to Discuss Their New ICO This Week The Digital Investment Forum launches this week to bring us some of the most respected thought leaders, fund managers, and policy makers in the cryptocurrency network. The forum includes talks on topics relevant to investors, professionals in the finance industry, investment strategies, talks on future investment opportunities, and discussions on new regulations. There will be new companies launching their products and leaders of the
Whats The Best Way To Invest Any Spare Money You Have?
Everyone is searching for new ways to invest and to keep their money as safe as possible… Imagine you have €75,000 to invest…. What is the best way you can invest it now? “Have a detailed look through your current portfolio and check if there are any of your assets that you should now invest more money into at lower prices or perhaps peek outside the box and look

More Releases for Lupus

Global Systemic Lupus Erythematosus and Lupus Nephritis Drugs Market US$ 1.8 Bil …
The global systemic lupus erythematosus and lupus nephritis drugs market expected to reach US$ 1.8 billion by 2021, growing at CAGR 7.4% over the forecast period 2017-2021. Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease that is characterized by systemic chronic inflammation that can affect multiple major organ systems. A major contributor to morbidity and mortality among patients with SLE is renal involvement, known as lupus nephritis (LN). Visit The
Systemic Lupus Erythematosus and Lupus Nephritis Market - Global Drug Forecast a …
Latest industry research report on: Systemic Lupus Erythematosus and Lupus Nephritis Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. As a multisystem disorder, SLE is heterogeneous in nature-no two cases of lupus are alike-and can affect multiple major organ systems in the
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Fore …
Recent research and the current scenario as well as future market potential of "PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 " globally. Summary Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. As a multisystem disorder, SLE is heterogeneous in nature-no two cases of lupus are alike-and can affect multiple
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) …
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H2, 2014”. This report provides data on the Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Cutaneous Lupus Erythematosus (CCLE)
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Fore …
"The Report PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" View Full Report : https://www.marketresearchreports.biz/reports/1045237/pharmapoint-systemic-lupus-erythematosus-and-market-research-reports Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune
Global Systemic Lupus Erythematosus and Lupus Nephritis Market to Display 10.6% …
"The Report PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" MarketResearchReports.biz has announced the addition of a new report, titled “PharmaPoint: Systemic Lupus Erythematosus And Lupus Nephritis - Global Drug Forecast And Market Analysis To 2025,” to its expanding repository of research reports. The market